The performance of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key markets has introduced substantial uncertainty . Investors are now grappling with the consequences of